STABILITY OF ACTIONABLE MUTATIONS IN PRIMARY AND RECURRENT GLIOBLASTOMAS

被引：0

作者：

French, P. J. ^{[1
]}

Taphoorn, M. ^{[2
]}

Weyerbrock, A. ^{[3
]}

Sanson, M. ^{[4
]}

Hoeben, A. ^{[5
]}

Lukavoca, S. ^{[6
]}

Lombardi, G. ^{[7
]}

Hanse, M. ^{[8
]}

Watts, C. ^{[9
]}

Golfinopoulos, V. ^{[10
]}

McDermott, U. ^{[11
]}

Robe, P. ^{[12
,13
]}

机构：

[1] Erasmus MC Hersentumorctr, Rotterdam, Netherlands

[2] MC Haaglanden, The Hague, Netherlands

[3] Univ Klinikum, Freiburg, Germany

[4] Hop Univ Pitie Salpetriere, Paris, France

[5] Maastricht UMC, Maastricht, Netherlands

[6] Aarhus Univ Hosp, Aarhus, Denmark

[7] Veneto Inst Oncol, Padua, Italy

[8] Elizabeth Hosp, Tilburg, Netherlands

[9] Addenbrookes Hosp, Cambridge, England

[10] EORTC Headquarters, Brussels, Belgium

[11] Wellcome Trust Sanger Inst, Hinxton, England

[12] UMC Utrecht, Utrecht, Netherlands

[13] CHU, Liege, Belgium

来源：

NEURO-ONCOLOGY | 2017年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P01.12

引用

页码：25 / 26

页数：2

共 50 条

[31] Actionable mutations in canine hemangiosarcoma
Wang, Guannan
Wu, Ming
Maloneyhuss, Martha A.
Wojcik, John
Durham, Amy C.
Mason, Nicola J.
Roth, David B.
[J]. PLOS ONE, 2017, 12 (11):
[32] Challenges with Approved Targeted Therapies against Recurrent Mutations in CLL: A Place for New Actionable Targets
Lopez-Oreja, Irene
Playa-Albinyana, Heribert
Arenas, Fabian
Lopez-Guerra, Monica
Colomer, Dolors
[J]. CANCERS, 2021, 13 (13)
[33] Analysis of Glioma Stem Cell Markers and Genomic Alterations in Primary and Recurrent Glioblastomas.
Appin, C. L.
Schniederjan, M. J.
Van Meir, E.
Mastrogianakis, G. M.
Brat, D. J.
[J]. MODERN PATHOLOGY, 2011, 24 : 378A - 379A
[34] Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas
Fokas, Emmanouil
Wacker, Ulrich
Gross, Markus W.
Henzel, Martin
Encheva, Elitsa
Engenhart-Cabillic, Rita
[J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (04) : 235 - 240
[35] GammaTile® brachytherapy in the treatment of recurrent glioblastomas
Gessler, Dominic J.
Neil, Elizabeth C.
Shah, Rena
Levine, Joseph
Shanks, James
Wilke, Christopher
Reynolds, Margaret
Zhang, Shunqing
Ozutemiz, Can
Gencturk, Mehmet
Folkertsma, Mark
Bell, W. Robert
Chen, Liam
Ferreira, Clara
Dusenbery, Kathryn
Chen, Clark C.
[J]. NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
[36] Gammatile Brachytherapy in the Treatment of Recurrent Glioblastomas
Chen, Clark C.
Dusenbery, Kathryn
Ferreira, Clara
Levine, Joseph
Shah, Rena
Shanks, Jim
Ma, Jun
Chen, Liam
Folkertsma, Mark
Gencturk, Mehmet
Gessler, Dominic
Neil, Elizabeth
Ozutemiz, Can
Reynolds, Margaret
Robert, Bell
Wilke, Christopher
Zhang, Shunqing
[J]. JOURNAL OF NEUROSURGERY, 2022, 136 (05)
[37] An Extent of Resection Threshold for Recurrent Glioblastomas
Oppenlander, Mark E.
Wolf, Andrew
Nakaji, Peter
Porter, Randall
Smith, Kris
Spetzler, Robert
Sanai, Nader
[J]. JOURNAL OF NEUROSURGERY, 2012, 117 (02) : A426 - A426
[38] RECURRENT GLIOBLASTOMAS AFTER TREATMENT WITH BEVACIZUMAB
Tabatabai, Ghazaleh
Felsberg, Joerg
Sabel, Michael
Kaulich, Kerstin
Hofer, Silvia
Westphal, Manfred
Weller, Michael
Reifenberger, Guido
[J]. NEURO-ONCOLOGY, 2014, 16
[39] AN EXTENT OF RESECTION THRESHOLD FOR RECURRENT GLIOBLASTOMAS
Oppenlander, Mark E.
Wolf, Andrew
Porter, Randall
Nakaji, Peter
Smith, Kris A.
Spetzler, Robert F.
Sanai, Nader
[J]. NEURO-ONCOLOGY, 2011, 13 : 155 - 155
[40] Bevacizumab for Patients with Recurrent Multifocal Glioblastomas
Burger, Michael C.
Breuer, Stella
Cieplik, Hans C.
Harter, Patrick N.
Franz, Kea
Baehr, Oliver
Steinbach, Joachim P.
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11):

← 1 2 3 4 5 →